24 HR quetiapine 50 MG Extended Release Oral Tablet — RxCUI 853201
RxNorm drug concept · Semantic clinical drug
RxCUI 853201
Semantic clinical drug · SCD
● Current RxNorm concept 62 FDA products
103 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI853201
Official name24 HR quetiapine 50 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asQUEtiapine fumarate 50 MG 24HR Extended Release Oral Tablet; quetiapine 50 MG (as quetiapine fumarate 58 MG) 24 HR Extended Release Oral Tablet
FDA products mapped62
Package NDCs mapped103
Reported Medicaid activity (SDUD)427,292 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Quetiapine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Quetiapine is approved to treat schizophrenia, bipolar disorder (both manic episodes and depressive episodes), and — in the extended-release form only — as an add-on to an antidepr...
- It depends on the form. If you're taking the regular tablet, you can take it with or without food — no restrictions. But if you're on the extended-release tablet, you should take i...
- Does it matter if I take quetiapine with food?
- Sleepiness is actually one of the most common side effects — in some studies, more than half of patients reported it. Quetiapine blocks histamine receptors in the brain, which has...
🕸️ Concept Web — How 24 HR quetiapine 50 MG Extended Release Oral Tab... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR quetiapine 50 MG Extended Release Oral Tablet
RxCUI 853201 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Quetiapine
51272IN
-
Quetiapine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Seroquel
83553BN
-
Seroquel
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Quetiapine Extended Release Oral Tablet
721790SCDF -
Quetiapine Oral Product
1157343SCDG -
Quetiapine Pill
1157344SCDG -
Quetiapine Extended Release Oral Tablet [Seroquel]
721792SBDF -
Seroquel Oral Product
1180762SBDG -
Seroquel Pill
1180763SBDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Quetiapine Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Quetiapine 50 MG
616486SCDC -
24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]
853202SBD -
Quetiapine 50 MG [Seroquel]
616488SBDC
-
Quetiapine 50 MG
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
-
{1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
1648647BPCK -
{1 (24 HR quetiapine 200 MG Extended Release Oral Tablet) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet) } Pack
1648646GPCK
-
{1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Quetiapine 50 MG
SCDC · 616486 -
Quetiapine Extended Release Oral Tablet
SCDF · 721790 -
Quetiapine Oral Product
SCDG · 1157343 -
Quetiapine Pill
SCDG · 1157344 -
{1 (24 HR quetiapine 200 MG Extended Release Oral Tablet) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet) } Pack
GPCK · 1648646
Brand-Name Concepts
-
24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]
SBD · 853202 -
Quetiapine 50 MG [Seroquel]
SBDC · 616488 -
Quetiapine Extended Release Oral Tablet [Seroquel]
SBDF · 721792 -
Seroquel Oral Product
SBDG · 1180762 -
Seroquel Pill
SBDG · 1180763 -
Seroquel
BN · 83553 -
{1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit]
BPCK · 1648647
📦 FDA Products & Package NDCs
62 products · 103 package NDCs
103 package NDCs map to RxCUI 853201 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00310-0281-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0281-60) | SEROQUEL XR | AstraZeneca Pharmaceuticals LP | 2009-02-01 |
| 00310-0282-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-60) | SEROQUEL XR | AstraZeneca Pharmaceuticals LP | 2007-07-16 |
| 00310-0283-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0283-60) | SEROQUEL XR | AstraZeneca Pharmaceuticals LP | 2007-07-16 |
| 00310-0284-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0284-60) | SEROQUEL XR | AstraZeneca Pharmaceuticals LP | 2007-07-16 |
| 00904-6801-61 | 100 BLISTER PACK in 1 CARTON (0904-6801-61) / 1 TABLET, FIL... | Quetiapine | Major Pharmaceuticals | 2017-08-22 |
| 00904-6802-61 | 100 BLISTER PACK in 1 CARTON (0904-6802-61) / 1 TABLET, FIL... | Quetiapine | Major Pharmaceuticals | 2017-08-22 |
| 00904-6803-61 | 100 BLISTER PACK in 1 CARTON (0904-6803-61) / 1 TABLET, FIL... | Quetiapine | Major Pharmaceuticals | 2017-08-22 |
| 00904-6804-61 | 100 BLISTER PACK in 1 CARTON (0904-6804-61) / 1 TABLET, FIL... | Quetiapine | Major Pharmaceuticals | 2017-08-22 |
| 00904-6805-61 | 100 BLISTER PACK in 1 CARTON (0904-6805-61) / 1 TABLET, FIL... | Quetiapine | Major Pharmaceuticals | 2017-08-22 |
| 16729-0132-12 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (16729-132-12) | QUETIAPINE FUMARATE | Accord Healthcare Inc. | 2017-11-30 |
| 29300-0308-16 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (29300-308-16) | Quetiapine | Unichem Pharmaceuticals (USA), Inc. | 2022-09-12 |
| 29300-0309-16 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (29300-309-16) | Quetiapine | Unichem Pharmaceuticals (USA), Inc. | 2022-09-12 |
| 29300-0310-16 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (29300-310-16) | Quetiapine | Unichem Pharmaceuticals (USA), Inc. | 2022-09-12 |
| 29300-0311-16 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (29300-311-16) | Quetiapine | Unichem Pharmaceuticals (USA), Inc. | 2022-09-12 |
| 29300-0312-16 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (29300-312-16) | Quetiapine | Unichem Pharmaceuticals (USA), Inc. | 2022-09-12 |
| 43547-0019-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-019-06) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0019-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-019-50) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0020-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-020-06) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0020-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-020-50) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0021-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-021-06) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0021-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-021-50) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0022-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-022-06) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0022-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-022-50) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0023-06 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-023-06) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 43547-0023-50 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43547-023-50) | QUETIAPINE | Solco Healthcare U.S., LLC | 2022-04-01 |
| 50228-0380-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (5022... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2018-11-16 |
| 50228-0380-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2018-11-16 |
| 50228-0380-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2018-11-16 |
| 50228-0381-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (5022... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0381-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0381-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0382-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (5022... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0382-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0382-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0383-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0383-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0383-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0384-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0384-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50228-0384-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-... | Quetiapine Extended Release | ScieGen Pharmaceuticals, Inc | 2017-11-29 |
| 50742-0635-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-635-10) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0635-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-635-30) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0635-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-635-60) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0635-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-635-90) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0636-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-10) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0636-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-30) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0636-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-60) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0636-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-636-90) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0637-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-637-10) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
| 50742-0637-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-637-30) | Quetiapine Fumarate | Ingenus Pharmaceuticals, LLC | 2017-08-31 |
Observed labelers:
Ingenus Pharmaceuticals, LLC (20) ·
Aurobindo Pharma Limited (15) ·
ScieGen Pharmaceuticals, Inc (15) ·
Solco Healthcare U.S., LLC (10) ·
ACI Healthcare USA, Inc. (5) ·
BluePoint Laboratories (5)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.